雌激素受体α突变,切断,异构体和治疗方法
Govinda R Hancock1, Jason Gertz2, Rinath Jeselsohn3,4,5
1Department of Cancer Biology, Loyola University Chicago Stritch School of Medicine, Maywood, IL 60513, USA.
Endocrinology
|April 21, 2024
概括
虽然激素疗法减少了乳腺癌死亡率,但许多患者仍然复发. 新的研究探讨了雌激素受体α (ERα) 的遗传变化,以克服内分泌疗法耐药性并提高治疗疗效.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 由于向雌激素受体α (ERα) 的激素疗法,乳腺癌 (BCa) 死亡率有所降低.
- 然而,大约50%的ER阳性高风险BCa患者在内分泌治疗后复发和转移,表明治疗不足.
- 对ERα的基因ESR1的基因组变化驱动了内分泌治疗耐药性和BCa进展.
研究的目的:
- 审查BCa.ERα信号传递的历史和当前理解.
- 探索ERα对抗性和异常信号在治疗阻力中的结构基础.
- 讨论内分泌疗法的演变和新兴药物开发策略.
主要方法:
- 对ERα的历史和当前研究的文献综述.
- 对ESR1与内分泌抵抗相关的基因组异常的分析.
- 对针对ERα的当前和未来治疗策略的调查.
主要成果:
- 包括放大和突变在内的ESR1遗传病变促进ERα活性和治疗耐药性.
- 异常的ERα信号驱动瘤的扩散,转移和逃避治疗.
- 针对ERα结构和转录关系的新疗法对抗抗性BCa有希望.
结论:
- 了解ERα的复杂作用和抵抗机制对于改善BCa结果至关重要.
- 准ERα异常为开发更有效的内分泌疗法提供了一个有希望的途径.
- 对ERα信号传递和药物开发的持续调查对于打击BCa转移和死亡率至关重要.
相关概念视频
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Enzyme-linked Receptors
78.3K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.3K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K


